Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Ma

Showing results (171-180 of 373) with videos related to

Pageof 38
Sort By:
Diabetes, Obesity & Metabolism|May 28, 2024
Association of dipeptidyl peptidase-4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variabilityJohnny T K Cheung, Aimin Yang, Hongjiang Wu, et al.
Diabetes Research and Clinical Practice|December 9, 2022
Initiation of sodium-glucose cotransporter-2 inhibitors at lower HbA1c threshold attenuates eGFR decline in type 2 diabetes patients with and without cardiorenal disease: A propensity-matched cohort studyJohnny T K Cheung, Aimin Yang, Hongjiang Wu, et al.
Plos Medicine|July 21, 2022
Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling studyXinge Zhang, Hongjiang Wu, Baoqi Fan, et al.
Diabetes Research and Clinical Practice|April 17, 2012
Use of thiazolidinedione and cancer risk in Type 2 diabetes: the Hong Kong diabetes registryXilin Yang, Wing-Yee So, Ronald C W Ma, et al.
Diabetologia|January 17, 2020
Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort studyHongjiang Wu, Eric S H Lau, Ronald C W Ma, et al.
Diabetes|March 17, 2007
Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic ratsEmi Arikawa, Ronald C W Ma, Keiji Isshiki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 19, 2011
Predictive role of multilocus genetic polymorphisms in cardiovascular disease and inflammation-related genes on chronic kidney disease in Type 2 diabetes--an 8-year prospective cohort analysis of 1163 patientsYing Wang, Andrea O Y Luk, Ronald C W Ma, et al.
Diabetes/Metabolism Research and Reviews|July 22, 2017
Glycaemia control and the risk of hospitalisation for infection in patients with type 2 diabetes: Hong Kong Diabetes RegistryAndrea O Y Luk, Eric S H Lau, Kitty K T Cheung, et al.
Plos Medicine|January 23, 2024
1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort studyHongjiang Wu, Aimin Yang, Eric S H Lau, et al.
Cardiovascular Diabetology|November 25, 2010
Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort studyRose Z W Ting, Xilin Yang, Linda W L Yu, et al.
Pageof 38

Showing results (171-180 of 373) with videos related to

Sort By:
Pageof 38
Diabetes, Obesity & Metabolism|May 28, 2024
Association of dipeptidyl peptidase-4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variabilityJohnny T K Cheung, Aimin Yang, Hongjiang Wu, et al.
Diabetes Research and Clinical Practice|December 9, 2022
Initiation of sodium-glucose cotransporter-2 inhibitors at lower HbA1c threshold attenuates eGFR decline in type 2 diabetes patients with and without cardiorenal disease: A propensity-matched cohort studyJohnny T K Cheung, Aimin Yang, Hongjiang Wu, et al.
Plos Medicine|July 21, 2022
Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling studyXinge Zhang, Hongjiang Wu, Baoqi Fan, et al.
Diabetes Research and Clinical Practice|April 17, 2012
Use of thiazolidinedione and cancer risk in Type 2 diabetes: the Hong Kong diabetes registryXilin Yang, Wing-Yee So, Ronald C W Ma, et al.
Diabetologia|January 17, 2020
Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort studyHongjiang Wu, Eric S H Lau, Ronald C W Ma, et al.
Diabetes|March 17, 2007
Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic ratsEmi Arikawa, Ronald C W Ma, Keiji Isshiki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 19, 2011
Predictive role of multilocus genetic polymorphisms in cardiovascular disease and inflammation-related genes on chronic kidney disease in Type 2 diabetes--an 8-year prospective cohort analysis of 1163 patientsYing Wang, Andrea O Y Luk, Ronald C W Ma, et al.
Diabetes/Metabolism Research and Reviews|July 22, 2017
Glycaemia control and the risk of hospitalisation for infection in patients with type 2 diabetes: Hong Kong Diabetes RegistryAndrea O Y Luk, Eric S H Lau, Kitty K T Cheung, et al.
Plos Medicine|January 23, 2024
1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort studyHongjiang Wu, Aimin Yang, Eric S H Lau, et al.
Cardiovascular Diabetology|November 25, 2010
Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort studyRose Z W Ting, Xilin Yang, Linda W L Yu, et al.
Pageof 38